BeOne Medicines
ONC
#643
Rank
NZ$62.66 B
Marketcap
NZ$566.33
Share price
1.26%
Change (1 day)
59.27%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): NZ$0.98

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$1.13. In 2024 the company made an earnings per share (EPS) of NZ-$10.81.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.98-109.04%
2024NZ-$10.81
2022NZ-$33.7828.21%
2021NZ-$26.35-19.96%
2020NZ-$32.9220.81%
2019NZ-$27.2531.52%
2018NZ-$20.72417.57%
2017NZ-$4.00-37.16%
2016NZ-$6.37158.95%
2015NZ-$2.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.65-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ-$0.42-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA